Naica System™ for Crystal™ Digital PCR

Please log in for more information

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Contact Information:

Stilla Technologies
1 Mail du professeur Georges Mathé
94 800 Villejuif
France
Email: [email protected]
Phone: +33982295050

Visit website

Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a innovative instrumentation for digital PCR (dPCR).

In 2016, Stilla Technologies launched the Naica System, the first and only digital PCR solution to offer 3-color multiplexing. By encapsulating all steps for digital PCR in a single chip, the Naica System offers a fast and user-friendly solution, rendering digital PCR accessible to all.

Stilla advises and supports its customers worldwide with a proactive and multidisciplinary R&D team, whose expertise spans from microfluidics and chemistry, to molecular biology and computer science.

Pillar Biosciences’ oncoReveal™ CDx Pan-Cancer Solid Tumor IVD: A Rapid FDA Approved NGS Kit to Help Drive Actionable and Accessible Localized Testing.

10/23/2024 | Sponsored by Illumina